EPGL Med ?@EPGLMed 18m Beneficial holders of majority shares remains same. PwC / AJW 2.0 billion. Hayes 2 billion.
EPGL Med ?@EPGLMed 20m Most revenues are wholesale. Cash and cash equivalents over $6mm. Share structure remains 499mm float, rest restricted.
EPGL Med ?@EPGLMed 22m EPGL Quarterly 2 out Thurs. Will report $5mm MPD1 sales due to Asia wholesale purchase commitments and US sales beginning in the quarter.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.